GPFT (Grapefruit USA) EBITDA Margin %: 0.00% (As of Sep. 2023)

What is Grapefruit USA EBITDA Margin %?

Grapefruit USA GPFT -10.71% EBITDA Margin % is 0.00% as of Sep. 2023.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Grapefruit USA's EBITDA for the three months ended in Sep. 2023 was $-0.11 Mil. Grapefruit USA's Revenue for the three months ended in Sep. 2023 was $0.00 Mil. Therefore, Grapefruit USA's EBITDA margin for the quarter that ended in Sep. 2023 was 0.00%.

Grapefruit USA (OTCPK:GPFT) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Grapefruit USA EBITDA Margin % Related Terms

Grapefruit USA EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for Grapefruit USA's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Grapefruit USA EBITDA Margin % Chart

Grapefruit USA Annual Data

Trend

Dec12

Dec13

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

EBITDA Margin %

Get a 7-Day Free Trial

9,583.33

0.00

-879.16

-5.80

-366.04

Grapefruit USA Quarterly Data
	Mar18	Jun18	Sep18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Sep23
EBITDA Margin %	Get a 7-Day Free Trial															13,050.00	-333.33	-3,695.83	-2,000.00	0.00

GPFT vs KAYS, KOAN, MJNE: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Grapefruit USA's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Grapefruit USA EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Grapefruit USA's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Grapefruit USA's EBITDA Margin % falls into.

Save Embed

Grapefruit USA EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Grapefruit USA's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2021 )	/	Revenue (A: Dec. 2021 )
	=	-2.156	/	0.589
	=	-366.04 %

Grapefruit USA's EBITDA Margin % for the quarter that ended in Sep. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Sep. 2023 )	/	Revenue (Q: Sep. 2023 )
	=	-0.107	/	0
	=	%

Frequently Asked Questions Learn more about EBITDA Margin % →

What does a EBITDA Margin % of 0.00% mean?

Grapefruit USA (GPFT) has a EBITDA Margin % of 0.00% as of Sep. 2023. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Grapefruit USA and its competitors.

Is Grapefruit USA's EBITDA Margin % too high?

Grapefruit USA's current EBITDA Margin % is 0.00%.

How does Grapefruit USA's EBITDA Margin % compare to KAYS and KOAN?

Grapefruit USA's EBITDA Margin % of 0.00% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.44. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good EBITDA Margin % for a Drug Manufacturers company?

The median EBITDA Margin % among Drug Manufacturers companies is 12.44, based on 955 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high EBITDA Margin % mean?

A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Grapefruit USA and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Grapefruit USA's current EBITDA Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Grapefruit USA stock overvalued right now?

Grapefruit USA (GPFT) has a current EBITDA Margin % of 0.00%. The current EBITDA Margin % is 0.00%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is EBITDA Margin % calculated?

EBITDA Margin % is calculated from a company's financial statements. For Grapefruit USA (GPFT), the current EBITDA Margin % is 0.00% as of Sep. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Grapefruit USA Business Description

Industry Healthcare Drug Manufacturers

Comparable Companies KAYS KOAN MJNE LRSV CSTF STMH KGKG CBDY CANB GCAN ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 XSWX:SDZ VTRS NBIX

Address 10850 Wilshire Boulevard, Suite 710, Los Angeles, CA, USA, 90024

Website https://www.grapefruitblvd.com

Grapefruit USA Inc currently has no operations. It is actively seeking a strategic merger partner with the goal of completing a business combination.